The US Food and Drug Administration (FDA) has approved French pharmaceutical company Sanofi's Dupixent, an anti-bronchitis drug for smokers.
According to the Washington Post, the drug's approval followed EU and Chinese approval, and was based on two studies that showed that Dupixent significantly reduced the progression of the disease and "improved respiratory function and quality of